CEL-SCI Corporation (NYSE:CVM) reported first quarter fiscal year 2023 results on February 15, 2023 and filed its Form 10-Q with the SEC. The company has continued to compile the clinical ...

CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA regarding their cancer immunotherapy. 9 Out of the Last 10 Summers this ...

CEL-SCI Corp. Annual stock financials by MarketWatch. View the latest CVM financial statements, income statements and financial ratios.

CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares. Historic Summer Setup: 3 "Power Patterns" Triggering in the next 75 Days - ...

The European Commission's interim Cooperation and Verification Mechanism Report revealed on Wednesday is expected to deal a serious blow to the country's efforts to join the Schengen Agreement soon.

WESTCHESTER, IL--(Marketwired - Dec 15, 2015) - CVM Solutions, a division of Kroll Compliance and the premier provider of supplier diversity technology, supplier data and services, officially ...